Thalidomide-5-CH2-NH2 hydrochloride is primarily used in research settings for its potential therapeutic applications, particularly in the field of oncology. It is studied for its anti-angiogenic properties, which inhibit the formation of new blood vessels, making it a candidate for treating cancers that rely on angiogenesis for growth and metastasis. Additionally, it is explored for its immunomodulatory effects, which may be beneficial in managing autoimmune diseases and certain inflammatory conditions. Researchers also investigate its role in targeted drug delivery systems, where its modified structure can enhance the specificity and efficacy of therapeutic agents.